This inventor holds 1 USPTO granted patent. Top assignees: Bristol-Myers Squibb Compnay, Virginia Tech Intellectual Properties Inc.. Active years: 1998.
Company Filing History:
1 out of 3,737 
1 out of 823 
Years Active: 1998
Title: Thomas J Altstadt: Innovator in Antitumor Agents
Introduction
Thomas J Altstadt is a notable inventor based in Middletown, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antitumor agents. His work has been recognized through his patent, which showcases his innovative approach to cancer treatment.
Latest Patents
Altstadt holds a patent for 7-deoxy-6-substituted paclitaxels. This invention concerns novel paclitaxel derivatives, their use as antitumor agents, and pharmaceutical formulations. The patent highlights his commitment to advancing cancer therapies and improving patient outcomes.
Career Highlights
Throughout his career, Altstadt has worked with prominent organizations, including Bristol-Myers Squibb Company and Virginia Tech Intellectual Properties Inc. His experience in these companies has allowed him to collaborate with leading experts in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include John F Kadow and David G Kingston. Their collective expertise has contributed to the success of various projects and innovations in the field.
Conclusion
Thomas J Altstadt's contributions to the development of antitumor agents exemplify his dedication to improving cancer treatment. His innovative spirit and collaborative efforts continue to inspire advancements in pharmaceuticals.